The retinoblastoma gene, rb, ensures at least its tumor suppressor function by inhibiting cell proliferation. Its role in apoptosis is more complex and less described than its role in cell cycle regulation. Rbf1, the Drosophila homolog of Rb, has been found to be pro-apoptotic in proliferative tissue. However, the way it induces apoptosis at the molecular level is still unknown. To decipher this mechanism, we induced rbf1 expression in wing proliferative tissue. We found that Rbf1-induced apoptosis depends on dE2F2/dDP heterodimer, whereas dE2F1 transcriptional activity is not required. Furthermore, we highlight that Rbf1 and dE2F2 downregulate two major anti-apoptotic genes in Drosophila: buffy, an anti-apoptotic member of Bcl-2 family and diap1, a gene encoding a caspase inhibitor. On the one hand, Rbf1/dE2F2 repress buffy at the transcriptional level, which contributes to cell death. On the other hand, Rbf1 and dE2F2 upregulate how expression. How is a RNA binding protein involved in diap1 mRNA degradation. By this way, Rbf1 downregulates diap1 at a post-transcriptional level. Moreover, we show that the dREAM complex has a part in these transcriptional regulations. Taken together, these data show that Rbf1, in cooperation with dE2F2 and some members of the dREAM complex, can downregulate the anti-apoptotic genes buffy and diap1, and thus promote cell death in a proliferative tissue.
The retinoblastoma gene (rb) is the first tumor suppressor identified in human cells. Its product, pRb, inhibits cell proliferation by controlling the G1/S transition. 1 The best characterized partners of pRB in cell cycle regulation belong to the E2F family of transcription factors. 2 In contrast to its tumor suppressor role, pRb is surprisingly often described as an anti-apoptotic protein. [3] [4] [5] [6] [7] [8] [9] [10] However, a growing number of studies show a pro-apoptotic role for pRb. [11] [12] [13] [14] Drosophila, which presents a lesser genetic complexity than mammals, offers the possibility to decipher the roles of Rb and E2F family proteins in apoptosis in vivo. Indeed, the Drosophila genome contains two E2F genes [15] [16] [17] (de2f1 and de2f2), one DP gene 15 (dDp) that encodes an E2F cofactor and two Rb genes 18, 19 (rbf1 and rbf2). dE2F1 acts mostly as a transcriptional activator, 20 whereas dE2F2 represses transcription. 21 As pRb protein in mammals, Rbf1 can bind both activator and repressor E2F members. 21 Furthermore, it fulfills the same function as pRb in the cell cycle. Rbf1 is thus considered as a pRb homolog. rbf1 loss-of-function is lethal at early larval stage 20, 22 that attests its essential role. Homozygous rbf1-mutant embryos have many apoptotic cells 22 and it is admitted that Rbf1 protects cells by inhibiting the transcriptional activity of dE2F1 that is considered as a pro-apoptotic factor. Indeed, de2f1 and dDp co-expression induces apoptosis in the eye imaginal discs 23 and the pro-apoptotic genes reaper and dark are dE2F1-transcriptional targets. 24, 25 In contrast to these data, we have previously shown that rbf1 can also have a proapoptotic function. Indeed, rbf1 overexpression in proliferating cells of wing imaginal discs leads to apoptosis and loss of tissue in adult wings. 26 This cell death is caspase dependent and can be inhibited by de2f1 expression. However, the precise mechanism underlying rbf1-induced apoptosis is still unknown. Rbf1 being mainly described as a transcriptional regulator, one may wonder whether this activity is involved in its pro-apoptotic effect. Recent reports have clarified the role of Rbf1 in transcription. Rbf1 binding to chromatin requires dE2F/dDP complexes. 27 This binding is mainly observed near transcription start sites (TSS). When associated with dE2F2, Rbf1 belongs to a transcription regulator complex named dREAM [28] [29] [30] (drosophila RBF, E2F and Myb-interacting proteins). This complex maintains the transcriptional repression of certain E2F target genes in the proliferating tissues by at least two distinct mechanisms: histone deacetylation of nucleosomes near TSSs and dimethylation of histone H3 Lys27 at nucleosomes located downstream of TSSs. 31 Although the first reports described the dREAM complex as 1 an exclusive transcriptional repressor, the recent ones showed that this complex is also required to maintain the expression of some genes, highlighting that it can also participate in transcriptional activation. 32 Several screens have identified Rbf1 target genes. 27, 32, 33 However, how the regulation of these genes is related to the different functions of Rbf1 remains to be explained. Notably, the targets of Rbf1 in apoptosis are not known.
Here we show that Rbf1-induced apoptosis results from transcriptional regulation of at least two genes by Rbf1 and dE2F2. First, Rbf1 and dE2F2 repress the expression of buffy, the anti-apoptotic member of the Bcl-2 family in Drosophila. Second, Rbf1 and dE2F2 activate the expression of how (held out wings), which encodes an RNA-binding protein that destabilizes diap1 (Drosophila inhibitor of apoptosis).
Result dE2F2 and dDP cooperate with Rbf1 to induce apoptosis. As previously described, overexpression of rbf1 in the dorsal region of wing imaginal discs using the UAS-Gal4 system with the 'vestigial' (vg) Gal4 driver induced notches along the wing margin. The number of notches correlated with the amount of apoptosis in wing imaginal discs of third instar larvae. 26 To determine the relative importance of the two dE2F factors in Rbf1-induced apoptosis, we performed genetic interaction tests. For each gene studied, we verified that the alteration of this gene expression level by itself (overexpression, RNAi or mutant) did not induce any wing phenotype, nor apoptosis at larval stage. Wing phenotypes were classified into four categories according to the number of notches: wild type (no notch), weak, intermediate and strong (Figure 1a ). Notches were counted in the wings of flies overexpressing rbf1 in a heterozygous dE2F2-mutant background (vg-Gal44UAS-Rbf1; dE2F2 76Q1 / þ ) and in flies simultaneously overexpressing rbf1 and de2f2 (vgGal44UAS-rbf1; UAS-dE2F2) (Figure 1b) . When rbf1 was overexpressed in dE2F2 76Q1 heterozygous context, a significant shift of the distribution toward weaker phenotypes was observed as compared with overexpression of rbf1 alone (Figure 1b) . On the contrary, when rbf1 and dE2F2 were co-overexpressed, the distribution significantly shifted toward stronger phenotypes. Thus, these results show that dE2F2 is necessary for Rbf1-induced notched wing phenotype. Previous data have shown that de2f1 heterozygous loss-of-function mutant context enhances rbf1-induced 76Q1 and vg-Gal44UAS-rbf1, UAS-de2f2 (b), in vg-Gal44UAS-rbf1 and vg-Gal44UAS-rbf1; dDp a1 (c), and in vg-Gal44UAS-rbf1 and vg-Gal44UAS-rbf1; de2f1 i2 (d). Statistical analysis was performed using Wilcoxon tests. Each experiment was independently performed three times; as the results were similar, only one experiment is presented here. (e-j) Apoptotic cells were visualized by TUNEL staining (white dots) of wing imaginal discs of the genotype indicated at the top of the image. All the pictures are at the same scale, scale bar: 100 mm. (k-m) Quantification of TUNEL-positive cells in the wing pouch. Asterisks indicate a statistically significant difference between two genotypes (Student's t-test, Po0.05) notched wing phenotype, showing that de2f1 antagonizes rbf1-induced phenotypes. 26 These results suggest that dE2F1 and dE2F2 have antagonistic roles in rbf1-induced notched wing phenotype. dDP is the cofactor shared by dE2F1 and dE2F2. In the absence of dDP, both dE2F1 and dE2F2 transcriptional activity is abolished. 34 In dDP   a1 heterozygote context, the rbf1-induced notched wing phenotypes significantly shifted toward weaker phenotypes ( Figure 1c ) as observed in dE2F2-mutant context. This result indicates that the reduction of the net transcriptional activity of dE2F factors due to dDp-mutant context rescues rbf1-induced loss of tissue. Thus, dE2F's net transcriptional activity promotes rbf1-induced notched wing phenotype. We used de2f1 i2 mutant to determine whether dE2F1 inhibitory role in rbf1-induced loss of tissue involved its transactivation domain. This dE2F1 mutant lacks both the transactivation domain and its ability to bind Rbf1. 20 However, it retains the DNA binding domain. By this way, it is able to bind dE2F consensus site and could exclude some complexes, such as dE2F2/Rbf1, from these genomic sites. 35 When rbf1 was overexpressed in a de2f1 i2 heterozygous context, the distribution of the phenotypes shifted toward weaker phenotypes as compared with the overexpression of rbf1 alone (Figure 1d ). Thus, dE2F1 i2 suppresses rbf1-induced loss of tissue and the transcriptional activation mediated by dE2F1 does not seem to be required to inhibit rbf1-induced loss of tissue.
To verify that the variation of the phenotypic distribution between these different genetic contexts correspond to a variation of the amount of apoptosis in larvae, we performed TUNEL staining of third instar larval wing imaginal discs. Few apoptotic cells were detected in vg-Gal4/ þ control (Figure 1e ). On the contrary, many cells were TUNEL labeled in vg-Gal4/ þ ; UAS-rbf1/ þ wing discs (Figure 1f ). When rbf1 was overexpressed in a de2f2 76Q1 , dDp a1 or de2f1 i2 context (Figures 1g-j) , we observed a significant decrease of TUNELlabeled cells as compared with the overexpression of rbf1 alone (Figures 1k-m) . On the contrary, when rbf1 and de2f2 were co-overexpressed, the number of apoptotic cells was significantly increased (Figures 1h and k) .
These data show that dE2F1 might inhibit Rbf1-induced apoptosis independently of its transactivation activity, whereas dE2F2 and dDP cooperate with Rbf1 to induce apoptosis in the wing imaginal disc, a proliferating tissue.
Rbf1 and dE2F2 induce a reduction of buffy and diap1 mRNA levels. dE2F2 is a well-known transcriptional repressor. To explain its role in rbf1-induced apoptosis, we hypothesized that an Rbf1/dE2F2 complex could repress anti-apoptotic genes, leading to cell death. We focused on the two bestdescribed anti-apoptotic factors in Drosophila, diap1 and buffy, which encode a caspase inhibitor and a member of the Bcl-2 family, respectively. When rbf1 was overexpressed under vg control, buffy mRNA were significantly decreased as compared with the control vg-Gal4/ þ (Figure 2a) . In contrast, when rbf1 was inactivated by RNAi (vg-Gal44UAS-RNAi-rbf1), buffy mRNA was significantly increased as compared with the control (Figure 2b ). The same result was obtained in dDP heterozygous loss-of-function context (data not shown). In dE2F2 76Q1 heterozygous larvae, the amount of buffy mRNA was similar to the one of the control vg-Gal4/ þ . When rbf1 was overexpressed in a dE2F2 76Q1 heterozygous context, the amount of buffy mRNA was similar to the one of the vg-Gal4/ þ control (Figure 2a ), indicating that dE2F2 is necessary for rbf1-induced buffy mRNA decrease. These data suggest that Rbf1 represses buffy in wing imaginal discs in a de2f2-dependent manner. Similarly, rbf1 overexpression induced a decrease of diap1 mRNA level dependent of dE2F2 (Figure 2c ). We did not observe any modification of diap1 mRNA levels when rbf1 was inactivated by RNAi (data not shown).
To verify whether the amount of buffy and diap1 mRNA correlated with rbf1-induced apoptosis, we performed genetic interaction tests. When rbf1 was overexpressed in a buffy H37 heterozygous context, distribution of the wing phenotypes shifted toward stronger phenotypes as compared with the overexpression of rbf1 alone (Figure 2d ). On the contrary, when rbf1 and buffy were co-overexpressed, distribution of the wing phenotypes shifted toward weaker phenotypes. The variation of the phenotypic distribution between these different genetic contexts correlated with a variation of the amount of apoptosis in wing imaginal discs ( Figure 2f ). These results suggest that the decrease of buffy mRNA is a part of the cell death mechanism induced by Rbf1.
When rbf1 was overexpressed and diap1 was simultaneously inactivated by RNAi, we observed an increase of notches in the wings (Figure 2e ) as well as an increase in the amount of apoptosis in wing imaginal discs ( Figure 2g ) as compared with the overexpression of rbf1 alone. On the contrary, we detected a phenotypic rescue when rbf1 and diap1 were co-overexpressed. This suggests that diap1 mRNA level reduction contributes to Rbf1-induced apoptosis.
Rbf1 and dE2F2 increase how mRNA leading to diap1 mRNA destabilization. Our data suggest that Rbf1 and dE2F2 could directly repress the transcription of diap1 and buffy. A putative E2F binding site is present in buffy 5 0 UTR but absent in diap1 (data not shown). To confirm that diap1 mRNA reduction was due to transcriptional regulation, we used a diap1-LacZ reporter transgene in en-Gal4/ þ control wing imaginal discs and en-Gal4; UAS-rbf1 wing imaginal discs. In posterior compartment, rbf1 overexpression slightly alter the b-Gal staining aspect as compared with the en-gal4/ þ control (Figures 3a and b) , probably due to the presence of apoptotic cells, but we could not observe a real staining decrease. Nevertheless, Diap1 protein had decreased in the posterior compartment upon rbf1 overexpression (Figure 3d ). These data suggest that rbf1 overexpression would induce a post-transcriptional reduction of diap1 mRNA.
Interestingly, it has been reported that diap1 is a target of How, an RNA-binding protein that belongs to the STAR family. 36 Two How isoforms have been described. The short isoform, How(S), is involved in mRNA stability and splicing. 37 The long isoform, How(L), binds the 3 0 UTR of target mRNAs, leading to their destabilization and their rapid degradation. diap1 is a target of How(L). 36 We used how stru loss-of-function mutant to determine the implication of How in Rbf1-induced apoptosis. When rbf1 was overexpressed in a how stru heterozygous context, distribution of the phenotypes significantly shifted toward weaker phenotypes as compared with the expression of rbf1 alone. Consistently, the number of apoptotic cells decreased in wing imaginal discs of the same genotype (Figures 3e and f) . Thus, How is, necessary for Rbf1-induced apoptosis. To confirm that How is involved in diap1 regulation, we performed RT-qPCR. In how stru heterozygotes, diap1 mRNA were slightly but significantly decreased indicating that How is required to maintain a basal level of diap1 mRNA (Figure 3g ). When rbf1 was overexpressed in a how stru heterozygous context, diap1 mRNA increased as compared with the rbf1 overexpression alone and even exceeded the level observed in vg-Gal4/ þ control. Therefore, these data suggest that Rbf1-induced apoptosis leads to diap1 mRNA destabilization by How.
To confirm whether diap1 downregulation by How in Rbf1-induced apoptosis involved diap1 3 0 UTR, we performed a genetic interaction test using a UAS-diap1 UY1835 transgenic line. This line bears a P element in the 5 0 UTR sequence of the diap1 gene, which allows overexpressing diap1 with its 3 0 UTR sequence. 38 Contrary to the phenotypic rescue observed when rbf1 was co-overexpressed with diap1 devoid of its 3 0 UTR sequence (Figure 2e ), rbf1co-overexpression with diap1 UY1835 did not lead to a rescue of notch phenotypes (Figure 3h ). Interestingly, diap1
UY1835 allowed an effective increase in the Diap1 protein level as attested by Diap1 immunostaining (Figure 3j ); however, this protein level was significantly lower when rbf1 was overexpressed (Figure 3k ). This suggests that Diap1 cannot accumulate in an rbf1-overexpressing context. When rbf1 and diap1
UY1835
were co-overexpressed in a how stru heterozygous context, the Diap1 protein accumulated (Figure 3l ) and consistently, we observed a significant rescue as compared with the expression of rbf1 in a how stru mutant context (Figure 3h, Wilcoxon test: n ¼ 308, ao10 -30 , Ws ¼ À 8.95). The variation of the phenotypic distribution between these different genetic contexts correlated with a variation of the amount of apoptosis in wing imaginal discs (Figure 3m) . Thus, the how stru heterozygote context prevents diap1 repression by , vg-Gal44UAS-rbf1; buffy H37 and vg-Gal44UAS-rbf1; UAS-buffy flies (d), vg-Gal44UAS-rbf1, vg-Gal44UAS-rbf1; UAS-RNAi-diap1 and vg-Gal44UAS-rbf1; UAS-diap1 flies (e). Wing phenotypes were grouped in four categories according to the number of notches (wild type, weak, intermediate, strong). Statistical analysis was performed using Wilcoxon tests. Each experiment was independently performed three times; as the results were similar, only one experiment is presented here. (f, g) Quantification of TUNEL-positive cells in the wing pouch. Asterisks indicate a statistically significant difference between two genotypes (Student's t-test, Po0.05) Figure 3 Rbf1 and dE2F2 increases how mRNA leading to diap1 mRNA destabilization. (a) diap1-lacZ transgene was used to report diap1 transcription in en-gal4/ þ and en-gal44UAS-rbf1 genetic contexts. b-Gal immunostaining (white) of the discs are shown in (a, b). Diap1 immunostaining (white) are shown in (c, d) and (i-l). The genotypes are indicated at the top of the image. Posterior compartment of the wing disc (on the right) is delimitated by dotted line when rbf1 is overexpressed. All the pictures presented in Figure 3 are at the same scale, scale bar: 100 mm. Distribution of notch wing phenotypes in vg-Gal44UAS-rbf1 and vg-Gal44UAS-rbf1; how stru flies (e), vg-Gal44UAS-rbf1, vg-Gal44UAS-rbf1; how stru , vg-Gal44UAS-rbf1; UAS-diap1 UY1835 and vg-Gal44UAS-rbf1; UAS-diap1 UY1835 ; how stru flies (h). Wing phenotypes were grouped into four categories according to the number of notches (wild type, weak, intermediate, strong). Statistical analysis was performed using Wilcoxon tests. Each experiment was independently performed three times; as the results were similar, only one experiment is presented here. Quantification of TUNEL-positive cells (f and m) in the wing pouch of genotypes studied in (e) and (h). Asterisks indicate a statistically significant difference between two genotypes (Student's t-test, Po0.05). Quantification of diap1 (g), how and how(L) (n) mRNAs in wing imaginal discs by RT-qPCR. Data are normalized against rp49 and correspond to the mean of three independent experiments. Error bars are the S.E.M. Asterisks indicate statistically significant difference between two genotypes (Student's t-test, Po0.05)
0 UTR sequence and How. We next asked whether rbf1 overexpression could affect the expression of how(L). Indeed, how(L) mRNA increased on rbf1 overexpression (Figure 3n) . Surprisingly, this raise depended on dE2F2 as it was reduced in a de2f2 76Q1 heterozygous context. This could be explained by an indirect effect of dE2F2, or by an unusual transcriptional activity of dE2F2. Thus, these data suggest that Rbf1 and dE2F2 increase of how(L) mRNA leads to destabilization of diap1 mRNA that induces apoptosis. 39 as a negative control. No significant enrichment was observed of the negative control slp1 after Rbf1 or dE2F2 immunoprecipitation (IP). In contrast, we detected a significant enrichment of the positive control pcna promoter region on Rbf1 or dE2F2 IP as compared with the mock IP (Figures 4a and b) . The buffy 5 0 UTR was significantly enriched after Rbf1 and dE2F2 IPs as compared with the negative controls both in rbf1-overexpressing wing discs and control discs (Figures 4a  and b) . Therefore, Rbf1 and dE2F2 bound buffy in the wing imaginal discs. Then, Rbf1 and dE2F2 might directly repress buffy transcription.
Rbf1 and dE2F2 binds
The how promoter also contains a putative dE2F binding site suggesting that Rbf1 and dE2F2 could bind this region. Consistently, we observed that how genomic region was significantly enriched after both Rbf1 and dE2F2 IP in rbf1-overexpressing wing discs (Figures 4a and b) . Nevertheless, these enrichments were not observed with the control discs. Despite the fact that Rbf1/dE2F2 complex is almost exclusively described as a transcriptional repressor, our results suggest that Rbf1 and dE2F2 might directly activate how transcription.
Transcriptional control by different members of the dREAM complex depends on the target gene. Rbf1 and dE2F2 belong to a multi-subunit complex named dREAM. This complex positively regulates some target genes, whereas it negatively regulates some others. Certain proteins of the complex are activators, whereas others are repressors or not involved. Moreover the role of each protein can change according to the target gene. To determine the function of the dREAM subunits Mip120, Mip130 and Myb in Rbf1-induced apoptosis, we performed genetic interaction tests. When rbf1 was co-overexpressed with either RNAimip120 or RNAi-mip130, the distribution of wing phenotypes shifted toward weaker phenotypes as compared with the expression of rbf1 alone (Figures 5a and b) . Consistently, the number of apoptotic cells decreased in the wing discs of the same genotypes (Figures 5d and e) , indicating that Mip120 and Mip130 were necessary for Rbf1-induced apoptosis.
rbf1 and myb co-expression induces a shift in the phenotype distribution toward weaker phenotypes ( Figure 5c ) and a decrease of apoptotic cells (Figure 5f ). Therefore, Myb is sufficient to inhibit Rbf1-induced apoptosis. This result is in an agreement with the antagonistic role of Myb as compared with the role of other members of the complex, previously described. 30 We next assessed the contribution of Mip120, Mip130 and Myb to buffy and how transcriptional regulation by RT-qPCR. Depletion of Mip120 or Mip130 by RNAi induced an increase of buffy mRNA as compared with vg-Gal4/ þ control (Figure 5g ), indicating that Mip120 and Mip130 are required to repress buffy expression in the wing imaginal discs. Moreover, when rbf1 was co-overexpressed with RNAi-mip120, buffy mRNA increased as compared with the rbf1 expression alone. Similar results were observed with RNAi-mip130, indicating that these two genes are required for Rbf1 to repress buffy expression. Depletion of Myb by RNAi did not affect buffy expression, whereas myb overexpression increased it (Figure 5h ). Furthermore, when rbf1 and myb were co-overexpressed, the amount of buffy mRNA was similar to the one of vg-Gal4/ þ control. Thus, Myb and Mip proteins had opposite roles on buffy Figure 4 Binding of Rbf1 and dE2F2 on buffy and how genes. Structure of buffy (a) and how (b) genes. qPCR amplicons are indicated. Coordinated of qPCR amplicons relative to TSS are indicated. ChIP-qPCR analysis of buffy (a) and how (b) from vg-gal44UAS-Rbf1 or control (vg-Gal4/ þ ) wing imaginal discs using mock, anti-Rbf1 or antidE2F2 antibodies. The results were expressed as percentages of input. slp1, a nontarget gene of Rbf1, was used as a negative control whereas pcna, a known dE2Fs target, was used as a positive control. Error bars represent S.E.M obtained from three independent experiments. Asterisks indicate statistically significant difference between two genotypes (Student's t-test, Po0.05) transcriptional regulation: whereas Myb activated buffy transcription, Mip factors repressed it.
Inactivation of Mip120 or Mip130 by RNAi did not affect the basal level of how mRNA (Figure 5i) . Moreover, when rbf1 was co-overexpressed with either RNAi-mip120 or RNAi-mip130, the amount of how mRNA was similar to the one observed for rbf1 overexpression alone, suggesting that these Mip factors are not involved in the transcriptional regulation of how by Rbf1.
Inactivation or overexpression of myb did not alter the basal amount of how mRNA (Figure 5j ). However, rbf1 and myb cooverexpression decreased the level of how mRNA as compared with the rbf1 overexpression alone. These data suggest that, contrary to dE2F2, Myb antagonizes Rbf1-induced how transcriptional activation.
Discussion
E2F transcription factors are the main partners of Rbf1. dE2F1 is widely described for its important role in the control of cell proliferation by Rbf1, whereas the best-described role of dE2F2 is the repression of replication during oogenesis. 35, 40 Here, we show that dE2F2 and dDP are required for Rbf1-induced apoptosis suggesting that they are pro-apoptotic factors, contrary to dE2F1, which inhibits this apoptosis. Until now, dE2F1 was mainly described as a pro-apoptotic factor, whereas dE2F2 was most of the time described as an antiapoptotic factor. Indeed, de2f1 and dDp co-expression induces apoptosis in the eye imaginal discs 23 and dE2F1 promotes irradiation-induced Dp53-independent apoptosis in wing Figure 5 Mip proteins and Myb are differentially involved in Rbf1-induced apoptosis. (a-c) Distribution of notch wing phenotypes in vg-Gal44UAS-rbf1,UAS-cherry and vg-Gal44UAS-rbf1,UAS-RNAi-mip120 (a), in vg-Gal44UAS-rbf1,UAS-cherry and vg-Gal44UAS-rbf1; UAS-RNAi-mip130 (b) and in vg-Gal44UAS-rbf1 and vg-Gal44UAS-rbf1; UAS-myb (c). Wing phenotypes were grouped in four categories according to the number of notches (wild type, weak, intermediate, strong). Statistical analysis was performed using Wilcoxon tests. Each experiment was independently performed three times; as the results were similar, only one experiment is presented here. 
imaginal discs, whereas dE2F2 inhibits apoptosis in the same model. 41 Recently, Rovani et al. 42 showed that the dREAM complex, which includes dE2F2, cooperates with the proapoptotic factor Grim to induce cell death in the peripheral nervous system. This result suggests a pro-apoptotic role for dE2F2, which is consistent with our results. Furthermore, the role of dE2F1 in apoptosis might depend on the cellular context. Indeed, dE2F1 is important for DNA damage-induced apoptosis in the wing imaginal discs, but its role varies depending on the position of the cell within the disc. 43 Together, this result and ours indicate that the role of both dE2F1 and dE2F2 in apoptosis control depends on the cellular context. Similarly, depending on the cells or tissues, Rbf1 has a pro-or antiapoptotic effect. Indeed, RBF expression induces apoptosis in different proliferative tissues, whereas this effect was not observed in differentiated post-mitotic cells. 26 RNAi-based studies suggested a requirement of buffy for cell survival during embryonic development. 44 Another study suggests that Buffy is not involved in developmental cell death but modulates the response to irradiation-induced cell death. 45 Here, we show that buffy is involved in apoptosis induced by overexpression of the tumor suppressor gene rbf1. Furthermore, our data reveal for the first time that Rbf1 regulates buffy transcription. It would thus be interesting to determine whether Rbf1 also regulates buffy in response to irradiation.
At least in some cancers, pRb oncosuppressor activity relies on its apoptosis-inducing activity. It has been suggested that RB mutations can affect the sensitivity to mitomycin/ anthracycline treatment in breast cancer. 46 Several reports underline the importance of pRb in the apoptotic response of prostate cancer cells to radiotherapy or chemotherapeutic drugs. 11, 12, 47 How pRb mediates apoptosis in these cases remains unclear. Other data show that DNA damage promotes the formation of a pRB/E2F1 complex involved in the activation of pro-apoptotic genes such as Caspase 7 and p73, 13 and that RB/E2F-1 is a major contributor of Noxa induction in response to ABT-737 treatment, a Bcl-2 inhibitor. 48 Thus, pRb/E2F proapoptotic signaling(s) can be activated in response to oncogenic stress, DNA damage or Bcl-2 inhibition. Similarly, our data show that in Drosophila, Rbf1/dE2F2 can regulate apoptosis by upregulating how (Figure 6 ). Although this regulation seems non-essential to maintain the how mRNA basal level, we cannot exclude that it occurs in response to some stresses and/or therapeutic treatments. Indeed, Quaking, the homolog of how, has been shown to be a tumor suppressor. [49] [50] [51] It would be interesting to study whether a pRb/E2F complex can regulate a mammalian homolog of the dIAP1 gene via Quaking.
Rbf1 and dE2F2 belong to a large complex called dREAM. Inactivation of members of dREAM by RNAi in Kc cells leads to variations of how and buffy expression, 32 which suggests that these two genes could be direct transcriptional targets of dREAM. Such as described by Georlette et al., 32 we found that the involvement of dREAM complex members are not equivalent: some members can be activators for a specific target, whereas others are repressors or are not involved in transcriptional regulation of this target. Indeed dE2F2, Mip120 and Mip130 are required for Rbf1-induced transcriptional repression of buffy, whereas Myb has an opposite effect. Moreover, contrary to dE2F2 and Myb, Mip120 and Mip130 are not involved in how regulation. dE2F2 and Myb have opposite effects on Rbf1-induced buffy and how transcription. Our results are in agreement with transcriptomic data indicating that there are no genes negatively co-regulated by Myb and dE2F2 but many genes are regulated both positively by Myb and negatively by dE2F2. 32 Our results confirm a previous report 32 indicating that Rbf1 and the dREAM complex can act both as a transcriptional activator and as a transcriptional repressor ( Figure 6 ). The molecular mechanisms for transcriptional repression have Figure 6 Rbf1-induced apoptosis involved transcriptional regulation of buffy and how genes. Rbf1 with dE2F2 binds buffy genomic site near to TSS and represses its transcription. The decrease of buffy mRNA contributes to Rbf1-induced apoptosis. Rbf1 can also bind how promoter with dE2F2 but this time it induces a transcriptional upregulation. As a consequence, How level increases allowing diap1 mRNA degradation which promotes Rbf1-induced cell death. Some members of the dREAM complex are involved in these transcriptional regulations Rbf1/dE2F2 induces diap1 and buffy downregulation A Clavier et al been deciphered. 31 It would be interesting to determine which epigenetic mechanisms are involved in the transcriptional activation of dREAM complex target genes.
Using an overexpression system, we have identified the bcl-2 family gene buffy, as a transcriptional target of Rbf1. In an rbf1 loss-of-function mutant, buffy transcription increases show that in wild-type cells not committed to apoptosis, Rbf1 is necessary to limit buffy expression. Thus, rbf1 loss of function could render cells more resistant to apoptosis. Identification of buffy as an Rbf1/dE2F pathway target gene is consistent with the role of tumor suppressor described for the human counterpart Rb. Transcriptional regulation of bcl-2 family genes by Rb/E2F complexes has also been characterized in mammals. Indeed, pRb/E2F1 directly regulates noxa, 48 bim 52 and puma. 53 Regulation by Rb of bcl-2 family gene expression may have a major impact on cell death and can thus contribute to its tumor suppressor action.
Materials and Methods
Fly stocks. Flies were raised at 25 1C on a standard medium. The UAS-Rbf1 and vg-Gal4 strains were generous gifts from J Silber. The en-Gal4 strain was kindly provided by L Théodore. The UAS-diap1 strain was a generous gift from A-M Pret. In this strain, a transgene containing diap1 cDNA under the control of a UAS sequence is inserted on the second chromosome and allows the expression of diap1 without its 3 0 UTR sequence. The UAS-diap1 UY1835 was a kind gift from S Netter. 38 In this transgenic line, a P element is inserted in the 5 0 UTR sequence of diap1 gene in the correct orientation to allow the expression of diap1 with its 3 0 UTR sequence. The following strains were obtained from the Bloomington Stock Center (Bloomington, IN, USA):
, UAS-myb (32044). The UAS-RNAi-diap1 strain was from NIG collection (12284R-2). The UAS-RNAi-rbf1 strain was from VDRC collection (10696).
Test of phenotype suppression in the wing. To test the implication of several genes (dE2F1, dE2F2, dDP, Buffy, Diap1, How, Mip120, Mip130 and Myb) in rbf1-induced apoptosis, the severity of the notched wing phenotype induced by UAS-Rbf1 overexpression led by vg-Gal4 driver was assayed in different genetic contexts. For each gene, we verified that the alteration of this gene expression level (overexpression, RNAi or mutant) did not induce any wing phenotype. vgGal4 4UAS-Rbf1 Drosophila females were crossed with males bearing a loss-offunction mutation for the different genes or allowing their overexpression. The progenies of all crosses were classified according to the number of notches on the wing margin. Wilcoxon tests were performed as described previously. 54 TUNEL staining of imaginal discs. Third instar larvae were dissected in PBS pH 7.6, fixed in PBS/formaldehyde 3.7%, washed three times for 10 min in PBT (1 Â PBS, 0.5% Triton). Discs were then dissected and TUNEL staining was performed according to manufacturer's instructions (ApopTag Red in situ apoptosis detection kit, Millipore, Temecula, CA, USA). Discs were mounted in CitifluorTM (Biovalley, Marne-La-Vallée, France) and observed with a Leica SPE upright confocal microscope (Leica, Wetzlar, Germany). White patches in the wing pouch were counted for at least 30 wing imaginal discs per genotype. Student's t-tests were performed and results were considered to be significant when ao 5%.
Immunochemistry. The following antibodies were used: anti-b-Gal (mouse monoclonal antibody, 1/200, 40-1a, DSHB) and anti-Diap1 (mouse monoclonal antibody, 1/200, generous gift from B Hay). Third instar larvae were dissected in PBS pH 7.6, fixed in PBS-3.7% formaldehyde, washed three times for 10 min each in PBT (PBS, 0,3% Triton) and incubated with primary antibody overnight at 4 1C in PBT-FCS (PBS, 0,3% Triton, 10% FCS). Incubation with anti-mouse secondary antibody (Alexa Fluor 488 Goat Anti-Mouse IgG (H þ L) Antibody, Molecular Probes, Thermo Fisher Scientific, Waltham, MA, USA) was carried in PBT-FCS for 2 h at room temperature. Larvae were then washed thrice in PBT. Finally, wing discs were mounted in CitifluorTM (Biovalley) and observed with a Leica SPE upright confocal microscope.
Chromatin immunoprecipitation. ChIPs were performed as previously described, 55 with minor modification. Briefly, 50 vg-Gal44UAS-rbf1 wing imaginal discs of third instar larvae were dissected on ice in serum-free Schneider medium. They were fixed in 500 ml of formaldehyde (1.8% in PBS) for 10 min at room temperature under gentle agitation. Cross-linking was stopped by adding 50 ml of glycine 1.25 M. Fixed wing discs were washed 3 times with PBS, dried, flash-freezed in liquid nitrogen and stored at À 80 1C. Cell lysis was performed by adding 100 ml of lysis buffer (140 mM NaCl, 10 mM Tris-HCl pH 8.0, 1 mM EDTA, 1% Triton X-100, 0.1% sodium deoxycholate, Roche complete EDTA-free protease inhibitor cocktail) complemented with 1% SDS and sonicated in a Bioruptor sonifier (Diagenode, Seraing, Belgium). Conditions were established to obtain chromatin fragments from 200 to 1000 bp in length (30 s ON 30 s OFF, high power, 10 cycles). Pooled chromatin was centrifuged for 20 min at 14 000 g at 4 1C. The supernatant (soluble chromatin) was recovered and 10 ml were kept as input sample. For each IP, 10 ml of protein A-coated paramagnetic beads (Diagenode) were washed once in lysis buffer, 1 mg of antibody was added and beads were incubated for 2 h at 4 1C on a rotating wheel. After washing in lysis buffer, antibody coated beads were resuspended in 300 ml of lysis buffer and 100 ml of chromatin were added. After incubation on a rotating wheel overnight at 4 1C, beads were washed at 4 1C five times for 10 min each in lysis buffer, once in LiCl buffer (Tris-HCl 10 mM pH8.0, LiCl 0.25 M, 0.5% NP-40, 0.5% sodium deoxycholate, 1 mM EDTA) and twice in TE (10 mM Tris-HCl, pH 8.0, 1 mM EDTA). Immunoprecipitated as well as input DNAs were purified with the IPure kit following the manufacturer's instructions (Diagenode). Elution was performed twice with 35 ml of water. 5 ml of DNA were used per PCR. Real-time PCR data were normalized against the input sample and depicted as percentage of input (see Supplementary Table S1 for primers). pcna, a well characterized target of Rbf1/dE2F complexes, was used as a positive control and slp1, a nontarget gene of Rbf1, 39 as a negative control. Antibodies used for chromatin immunoprecipitation were anti-Rbf1 (rabbit polyclonal, Custom antibody against amino acids 250-845 of Rbf1 protein, Proteogenix, Schiltigheim, France), anti-dE2F2 (rabbit polyclonal, Custom antibody against the whole protein, Proteogenix). Rabbit pre-immune sera were used as negative controls (mocks).
RNAs extraction and RT-qPCR. Fifty wing imaginal discs per genotype were dissected on ice in serum-free Schneider medium. Total RNAs were extracted from each sample using the RNeasy Mini kit (Qiagen, Venlo, Netherlands), by following the manufacturer's instructions. RT was performed on each sample using 4.8 mg of RNA incubated with random primer oligonucleotides (Invitrogen, Life Technologies, Carlsbad, CA, USA) with Recombinant Taq DNA Polymerase (Invitrogen), according to the manufacturer's instructions.
Real-time PCR analysis was performed using the ABI Prism 7700 HT apparatus (Applied Biosystems, Life Technologies). Briefly, PCR was performed with the ABsolute blue QPCR SYBR Green ROX mix (Abgene, Thermo Fisher Scientific), using 11 ng of cDNA per RT. The primers used for real-time PCR are presented in Supplementary Table S2 . Data were normalized against rp49. Three independent RT experiments were performed and the S.E.M was calculated from these three independent samples.
